OpenLegislation

The National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) (Amendment) Regulations 2011 in England

S.I. 2011/680 · Made 3 March 2011

Original text. legislation.gov.uk does not revise statutory instruments, so later amendments are not shown here. Changes made to it are listed under each provision when known.

National Health Service, England

Made 3rd March 2011

Laid before Parliament 11th March 2011

Coming into force 20th April 2011

The Secretary of State for Health makes these Regulations in exercise of the powers conferred by sections 88 and 272(7) and (8) of the National Health Service Act 2006f1.

Annotations to the whole text

Footnotes

f1

2006 c.41. See section 275(1) of the Act for the definitions of “prescribed” and “regulations” which are relevant to the powers being exercised in the making of these Regulations.

Contents

  1. 1Citation, commencement and application
  2. 2Amendment of the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004
  3. Signature
  4. Explanatory note

1Citation, commencement and application

(1)

These Regulations may be cited as the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) (Amendment) Regulations 2011 and come into force on 20th April 2011.

(2)

These Regulations apply in relation to England.

2Amendment of the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004

(1)

Schedule 2 (drugs, medicines and other substances that may be ordered only in certain circumstances) to the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004f1 is amended as follows.

(2)

For the entry for “Oseltamivir (Tamiflu)” which is referred to in column 1, in the part which relates to “treatment of influenza” (as mentioned in column 3) in column 2, in paragraph (1), insert “or who is aged under 65 years and is at risk of developing medical complications from influenza,” after “aged 65 years or over,”.

(3)

For the entry for “Zanamivir (Relenza)” which is referred to in column 1, in the part which relates to “treatment of influenza” (as mentioned in column 3) in column 2, in paragraph (1), insert “or who is aged under 65 years and is at risk of developing medical complications from influenza,” after “aged 65 years or over,”.

Signature

Signed by authority of the Secretary of State for Health.

Earl Howe

Parliamentary Under-Secretary of State,

Department of Health

3rd March 2011

Explanatory note

(This note is not part of the Regulations)

These Regulations amend the National Health Service (General Medical Services Contracts) (Prescription of Drugs etc.) Regulations 2004 (S.I. 2004/629).

Regulation 2 amends Schedule 2 so that the description of persons in respect of which Oseltamivir and Zanamivir may in certain circumstances be ordered is widened to include those who are under 65 years of age, who are not pregnant, nor considered to be at clinical risk, but who are considered to be at risk of developing complications from the symptoms of influenza.

A full impact assessment has not been produced for the instrument as no impact on the private or voluntary sector is foreseen.